The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
PBC Screen: An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis
Abstract
A dual isotype (IgG, IgA) enzyme-linked immunosorbent assay (ELISA) designed to provide enhanced detection of primary biliary cirrhosis (PBC)-specific autoantibodies against both major mitochondrial and nuclear antigens has been developed and recently become commercially available. The assay (PBC Screen) simultaneously detects IgG and IgA autoantibodies to the immunodominant portions of the 3 major mitochondrial (MIT3) and nuclear (gp210, and sp100) antigens. The aim of this study was to compare the performance of the PBC Screen to the combined performance obtained with individual IgG ELISAs to MIT3, gp210, and sp100 on a large group of selected patients from multiple centers. A total of 1175 patients with PBC and 1232 subjects without PBC were evaluated. Non-PBC groups included healthy controls (624) as well as individuals with autoimmune hepatitis (281), primary sclerosing cholangitis (77), viral hepatitis (91 hepatitis B and 98 hepatitis C), other liver diseases (31), and other infectious or autoimmune diseases (30). The PBC Screen at the receiver operator characteristic optimized cutoff of 27.8 units, had an overall sensitivity of 83.8%, specificity of 94.7% and area under curve of 0.9212. This was similar to the specificity of 96.1% obtained by the combined results of individual MIT3, sp100, and gp210 IgG ELISAs (kappa index at 0.898). Of the 253 PBC patients without AMA detectable by immunofluorescence, 113 (44.7%) were interpreted as positive for PBC-specific autoantibodies. In conclusion, the PBC Screen is an appropriate first-line test for the diagnosis of PBC, including for patients negative for markers assessed using conventional methods.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Approximately 5% of patients with PBC are negative for AMA (or anti PDC-E2/M2 by ELISA), although this figure in practice reflects the assays employed.263 264”
From The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines (2018) · cites this paper as [264]
Citations
Cites
Alvarez, F., Berg, P. A., Bianchi, F. B., Bianchi, L., Burroughs, A. K., Cancado, E. L., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V. J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80297-9 · Cited by 2,903
Self-citationKaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 2,016
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Schwab, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,241
Kaplan, M. M., & Gershwin, M. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043898 · Cited by 1,144
Self-citationLindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
(2015) · Elsevier eBooks · doi:10.1016/b978-0-323-37755-3.50202-6 · Cited by 808
Krawitt, E. L. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050408 · Cited by 762
Self-citationStaging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
Ludwig, J., Dickson, E. R., & McDonald, G. S. A. (1978) · Virchows Archiv A Pathological Anatomy and Histology · doi:10.1007/bf00432479 · Cited by 753
Invernizzi, P., Podda, M., Battezzati, P. M., Crosignani, A., Zuin, M. G., Hitchman, E., Maggioni, M., Meroni, P. L., Penner, E., & Węsierska‐Gądek, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00040-4 · Cited by 454
Self-citation
Flagged first, then by citations
2 of the 46 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Hirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Self-citationHirschfield, G. M., Dyson, J. K., Alexander, G. J. M., Chapman, M. H., Collier, J., Hübscher, S., Patanwala, I., Pereira, S. P., Thain, C., Thorburn, D., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315259 · Cited by 362
Self-citationA randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
Kowdley, K. V., Luketic, V., Chapman, R., Hirschfield, G. M., Poupon, R., Schramm, C., Vincent, C., Rust, C., Parés, A., Mason, A., et al. (2018) · Hepatology · doi:10.1002/hep.29569 · Cited by 281
Self-citationLleo, A., Wang, G.-Q., Gershwin, M. E., & Hirschfield, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31607-x · Cited by 253
Self-citationEnzyme-Linked Immunosorbent Assay: Types and Applications
Hayrapetyan, H., Tran, T. T., Tellez‐Corrales, E., & Madiraju, C. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2903-1_1 · Cited by 208
Current understanding of primary biliary cholangitis
Tanaka, A. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0028 · Cited by 169
Primary biliary cirrhosis and Sjögren’s syndrome: Autoimmune epithelitis
Selmi, C., Meroni, P. L., & Gershwin, M. E. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.11.005 · Cited by 145
Self-citationYou, H., Ma, X., Efe, C., Wang, G., Jeong, S.-H., Abe, K., Duan, W., Chen, S., Kong, Y., Zhang, D., et al. (2022) · Hepatology International · doi:10.1007/s12072-021-10276-6 · Cited by 133
Infectome: A platform to trace infectious triggers of autoimmunity
Bogdanos, D. P., Smyk, D. S., Invernizzi, P., Rigopoulou, E. I., Blank, M., Pouria, S., & Shoenfeld, Y. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.12.005 · Cited by 113
Self-citationAsialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: Lost and found
Rigopoulou, E. I., Roggenbuck, D., Smyk, D. S., Liaskos, C., Mytilinaiou, M. G., Feist, E., Conrad, K., & Bogdanos, D. P. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.04.005 · Cited by 108
Self-citationGastrointestinal involvement in systemic sclerosis
Savarino, E. V., Furnari, M., de Bortoli, N., Martinucci, I., Bodini, G., Ghio, M., & Savarino, V. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.03.029 · Cited by 100
Disease-specific autoantibodies in primary biliary cirrhosis
Bogdanos, D. P., & Komorowski, L. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.12.019 · Cited by 95
Self-citationAntinuclear antibodies as ancillary markers in primary biliary cirrhosis
Granito, A., Muratori, P., Quarneti, C., Παππάς, Γ., Cicola, R., & Muratori, L. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.11.82 · Cited by 86
Karlsen, T. H., Vesterhus, M. N., & Boberg, K. M. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12581 · Cited by 86
Performance Parameters of the Conventional Serological Markers for Autoimmune Hepatitis
Czaja, A. J. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1501-1 · Cited by 81
Self-citationSahebjam, F., & Vierling, J. M. (2015) · Frontiers of Medicine · doi:10.1007/s11684-015-0386-y · Cited by 87
Bizzaro, N., Covini, G., Rosina, F., Muratori, P., Tonutti, E., Villalta, D., Pesente, F., Alessio, M. G., Tampoia, M., Antico, A., et al. (2012) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-010-8234-y · Cited by 79
Self-citationWang, J. J., Yang, G.-X., Zhang, W. C., Lu, L., Tsuneyama, K., Kronenberg, M., Véla, J. L., Lopez-Hoyos, M., He, X.-S., Ridgway, W. M., et al. (2014) · Clinical and Experimental Immunology · doi:10.1111/cei.12224 · Cited by 74
Self-citationThe limitations and hidden gems of the epidemiology of primary biliary cirrhosis
Podda, M., Selmi, C. F., Lleò, A., Moroni, L., & Invernizzi, P. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.06.015 · Cited by 71
Self-citationAutoimmunity and Environment: Am I at risk?
Smyk, D. S., Rigopoulou, E. I., Baum, H., Burroughs, A. K., Vergani, D., & Bogdanos, D. P. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-011-8259-x · Cited by 68
Self-citationClinical Significance of Autoantibodies in Primary Biliary Cirrhosis
Nakamura, M. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1383732 · Cited by 69
Environment and primary biliary cirrhosis: Electrophilic drugs and the induction of AMA
Leung, P. S. C., Wang, J., Naiyanetr, P., Kenny, T. P., Lam, K. S., Kurth, M. J., & Gershwin, M. E. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.12.007 · Cited by 66
Self-citationAutoimmune Hepatitis and Overlap Syndromes: Diagnosis and Management
Vierling, J. M. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.08.012 · Cited by 67
Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis
Chen, R. C. Y., Naiyanetr, P., Shu, S.-A., Wang, J., Yang, G., Kenny, T. P., Guggenheim, K. G., Butler, J. D., Bowlus, C. L., Tao, M., et al. (2012) · Hepatology · doi:10.1002/hep.26157 · Cited by 65
Self-citationDiagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis
Liberal, R., Grant, C. R., Sakkas, L. I., Bizzaro, N., & Bogdanos, D. P. (2013) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2013.04.005 · Cited by 68
Self-citationGatselis, N., Zachou, K., Norman, G., Gabeta, S., Papamichalis, P., Koukoulis, G., & Dalekos, G. (2013) · Autoimmunity · doi:10.3109/08916934.2013.801461 · Cited by 67
Self-citationA novel automated indirect immunofluorescence autoantibody evaluation
Kivity, S., Gilburd, B., Agmon‐Levin, N., Carrasco, M. G., Tzafrir, Y., Sofer, Y., Mandel, M., Buttner, T., Roggenbuck, D., Matucci‐Cerinic, M., et al. (2011) · Clinical Rheumatology · doi:10.1007/s10067-011-1884-1 · Cited by 61
Rong, G., Zhong, R., Lleò, A., Leung, P. S. C., Bowlus, C. L., Yang, G., Yang, C., Coppel, R. L., Ansari, A. A., Cuebas, D. A., et al. (2011) · Hepatology · doi:10.1002/hep.24355 · Cited by 62
Self-citationHu, S., Zhao, F.-R., Wang, Q., & Chen, W. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-0926 · Cited by 63
Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., & Vergani, D. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.004 · Cited by 61
Self-citationMytilinaiou, M. G., Meyer, W., Scheper, T., Rigopoulou, E. I., Probst, C., Koutsoumpas, A. L., Abeles, D., Burroughs, A. K., Komorowski, L., Vergani, D., et al. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.03.020 · Cited by 60
Self-citationSelmi, C. F., & Gershwin, M. E. (2017) · Rheumatology and Therapy · doi:10.1007/s40744-017-0074-2 · Cited by 57
Self-citationVitamin D in autoimmune liver disease
Smyk, D. S., Orfanidou, T., Invernizzi, P., Bogdanos, D. P., & Lenzi, M. (2013) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2013.05.016 · Cited by 54
Self-citationLiver auto-immunology: The paradox of autoimmunity in a tolerogenic organ
Invernizzi, P. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.08.006 · Cited by 56
Self-citationSex Differences Associated with Primary Biliary Cirrhosis
Smyk, D. S., Rigopoulou, E. I., Parés, A. R., Billinis, C., Burroughs, A. K., Muratori, L., Invernizzi, P., & Bogdanos, D. P. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/610504 · Cited by 56
Self-citationPrimary Biliary Cirrhosis Associated with Systemic Sclerosis: Diagnostic and Clinical Challenges
Rigamonti, C., Bogdanos, D. P., Mytilinaiou, M. G., Smyk, D. S., Rigopoulou, E. I., & Burroughs, A. K. (2011) · International Journal of Rheumatology · doi:10.1155/2011/976427 · Cited by 56
Self-citationEpstein-Barr Virus as a Trigger of Autoimmune Liver Diseases
Rigopoulou, E. I., Smyk, D. S., Matthews, C. E., Billinis, C., Burroughs, A. K., Lenzi, M., & Bogdanos, D. P. (2012) · Advances in Virology · doi:10.1155/2012/987471 · Cited by 55
Self-citationThe fingerprint of antimitochondrial antibodies and the etiology of primary biliary cholangitis
Shuai, Z., Wang, J., Badamagunta, M., Choi, J., Yang, G., Zhang, W., Kenny, T. P., Guggenheim, K. G., Kurth, M. J., Ansari, A. A., et al. (2017) · Hepatology · doi:10.1002/hep.29059 · Cited by 50
Self-citationLong-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis
Juliusson, G., Imam, M., Björnsson, E. S., Talwalkar, J. A., & Lindor, K. D. (2016) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1132337 · Cited by 47
Urinary tract infection as a risk factor for autoimmune liver disease: From bench to bedside
Smyk, D. S., Bogdanos, D. P., Kriese, S., Billinis, C., Burroughs, A. K., & Rigopoulou, E. I. (2011) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2011.07.013 · Cited by 46
Self-citationRheumatic Manifestations in Autoimmune Liver Disease
Selmi, C. F., Generali, E., & Gershwin, M. E. (2017) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2017.09.008 · Cited by 47
Self-citationSmyk, D. S., Rigopoulou, E. I., Muratori, L., Burroughs, A. K., & Bogdanos, D. P. (2012) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31481-4 · Cited by 41
Self-citationDiagnosis of primary biliary cirrhosis
Hirschfield, G. M. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.10.005 · Cited by 41
Self-citationMeta-Analysis Assessment of GP210 and SP100 for the Diagnosis of Primary Biliary Cirrhosis
Hu, S., Zhao, F.-R., Hu, Q., & Chen, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101916 · Cited by 40
Terziroli Beretta-Piccoli, B., Stirnimann, G., Mertens, J., Semela, D., Zen, Y., Mazzucchelli, L., Voreck, A., Kolbus, N., Merlo, E., Di Bartolomeo, C., et al. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102578 · Cited by 39
Self-citationPrimary Biliary Cirrhosis: Family Stories
Smyk, D. S., Cholongitas, Ε., Kriese, S., Rigopoulou, E. I., & Bogdanos, D. P. (2011) · Autoimmune Diseases · doi:10.4061/2011/189585 · Cited by 39
Self-citationKawata, K., Kobayashi, Y., Gershwin, M. E., & Bowlus, C. L. (2012) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-012-8324-0 · Cited by 39
Self-citationTracing environmental markers of autoimmunity: introducing the infectome
Bogdanos, D. P., Smyk, D. S., Invernizzi, P., Rigopoulou, E. I., Blank, M., Sakkas, L. I., Pouria, S., & Shoenfeld, Y. (2013) · Immunologic Research · doi:10.1007/s12026-013-8399-6 · Cited by 38
Self-citationAUTOANTIBODIES BY LINE IMMUNOASSAY IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS
Saito, H., Takahashi, A., Abe, K., Okai, K., Katsushima, F., Monoe, K., Kanno, Y., & Ohira, H. (2012) · FUKUSHIMA JOURNAL OF MEDICAL SCIENCE · doi:10.5387/fms.58.107 · Cited by 37
Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value
Sciascia, S., Bizzaro, N., Meroni, P. L., Bogdanos, D. P., Borghi, M. O., Bossuyt, X., Grossi, C., Tornai, D., Papp, M., Shoenfeld, Y., et al. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103356 · Cited by 41
Self-citationPrimary biliary cirrhosis and the nuclear pore complex
Duarte-Rey, C., Bogdanos, D. P., Yang, C., Roberts, K., Leung, P. S. C., Anaya, J., Worman, H. J., & Gershwin, M. E. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.03.005 · Cited by 36
Self-citationMolecular diagnostic testing for primary biliary cholangitis
Gatselis, N., & Dalekos, G. N. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1217159 · Cited by 35
Self-citationVillalta, D., Sorrentino, M. C., Girolami, E., Tampoia, M., Alessio, M. G., Brusca, I., Daves, M., Porcelli, B., Barberio, G., & Bizzaro, N. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.08.024 · Cited by 35
Self-citationInfantino, M. G., Meacci, F., Grossi, V., Manfredi, M., Benucci, M., Merone, M., & Soda, P. (2016) · Immunologic Research · doi:10.1007/s12026-016-8845-3 · Cited by 35
Tanaka, T., Zhang, W., Sun, Y. H., Shuai, Z., Chida, A. S., Kenny, T. P., Yang, G., Sanz, I., Ansari, A. A., Bowlus, C. L., et al. (2017) · Hepatology · doi:10.1002/hep.29245 · Cited by 34
Self-citationHuang, C., Han, W., Wang, C., Liu, Y., Chen, Y., & Duan, Z. (2019) · Disease Markers · doi:10.1155/2019/9121207 · Cited by 32
Diagnosis and Treatment of Autoimmune Hepatitis
Vierling, J. M. (2011) · Current Gastroenterology Reports · doi:10.1007/s11894-011-0236-2 · Cited by 32
Role of autoantibodies in the clinical management of primary biliary cholangitis
Rigopoulou, E. I., & Bogdanos, D. P. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i12.1795 · Cited by 30
Self-citationAutoimmune diagnostics: the technology, the strategy and the clinical governance
Bizzaro, N., Tozzoli, R., & Villalta, D. (2014) · Immunologic Research · doi:10.1007/s12026-014-8587-z · Cited by 29
Self-citationInvernizzi, P., Alessio, M. G., Smyk, D. S., Lleo, A., Sonzogni, A., Fabris, L., Candusso, M., Bogdanos, D. P., Iorio, R., & Torre, G. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-92 · Cited by 28
Self-citationVillalta, D., Seaman, A., Tiongson, M., Warren, C., Bentow, C., Bizzaro, N., Alessio, M. G., Porcelli, B., Norman, G. L., & Mähler, M. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0122 · Cited by 27
Self-citationShimoda, S., Tsuneyama, K., Kikuchi, K., Harada, K., Nakanuma, Y., Nakamura, M., Ishibashi, H., Hisamoto, S., Niiro, H., Leung, P. S. C., et al. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2012.04581.x · Cited by 26
Self-citationSelmi, C. F. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.06.004 · Cited by 25
Norman, G. L., Reig, A., Viñas, O., Mähler, M., Wunsch, E., Milkiewicz, P., Swain, M. G., Mason, A. L., Stinton, L. M., Aparicio, M. B., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00662 · Cited by 25
Self-citationMoritoki, Y., Tsuda, M., Tsuneyama, K., Zhang, W., Yoshida, K., Lian, Z.-X., Yang, G., Ridgway, W. M., Wicker, L. S., Ansari, A. A., et al. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.01.005 · Cited by 23
Self-citationMaking Sense of Autoantibodies in Cholestatic Liver Diseases
Marzorati, S., Invernizzi, P., & Lleo, A. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.08.003 · Cited by 23
Self-citationAntimitochondrial Antibody–Negative Primary Biliary Cholangitis
Chascsa, D. M. H., & Lindor, K. D. (2018) · Clinics in Liver Disease · doi:10.1016/j.cld.2018.03.009 · Cited by 23
Xu, Q., Zhu, W., & Yin, Y. (2023) · Medicine · doi:10.1097/md.0000000000036039 · Cited by 20
The Importance of Autoantibody Detection in Primary Biliary Cirrhosis
Cançado, E. L. R., & Harriz, M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00309 · Cited by 20
Geoepidemiology and changing mortality in primary biliary cholangitis
Floreani, A., Tanaka, A., Bowlus, C. L., & Gershwin, M. E. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-017-1333-2 · Cited by 20
Self-citationVariant and Specific Forms of Autoimmune Cholestatic Liver Diseases
Dalekos, G. Ν., & Gatselis, N. (2019) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-019-00550-9 · Cited by 20
Self-citationOlianas, A., Guadalupi, G., Cabras, T., Contini, C., Serrao, S., Iavarone, F., Castagnola, M., Messana, I., Onali, S., Chessa, L., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24020959 · Cited by 18
Hair dyes as a risk for autoimmunity: from systemic lupus erythematosus to primary biliary cirrhosis
Smyk, D. S., Rigopoulou, E. I., Bizzaro, N., & Bogdanos, D. P. (2012) · Autoimmunity Highlights · doi:10.1007/s13317-011-0027-7 · Cited by 17
Self-citationYang, C.-Y., Leung, P., Yang, G.-X., Kenny, T., Zhang, W.-C., Coppel, R., Norman, G., Ansari, A., Mackay, I., Worman, H., et al. (2012) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2012.04577.x · Cited by 17
Self-citationBauer, A., Habior, A., & Gaweł, D. (2022) · Biomedicines · doi:10.3390/biomedicines10040801 · Cited by 15
Autoantibodies in Primary Biliary Cholangitis
Leung, K. K., & Hirschfield, G. M. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.06.004 · Cited by 15
Self-citationXenobiotics and autoimmunity: does acetaminophen cause primary biliary cirrhosis?
Leung, P. S. C., Lam, K. S., Kurth, M. J., Coppel, R. L., & Gershwin, M. E. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.07.005 · Cited by 16
Self-citationToward precision medicine in primary biliary cholangitis
Carbone, M., Ronca, V., Bruno, S., Invernizzi, P., & Mells, G. F. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.05.023 · Cited by 15
Self-citationGatselis, N., Zachou, K., Montaño‐Loza, A. J., Cançado, E. L. R., Arinaga‐Hino, T., Muratori, P., Efe, C., Floreani, A., Invernizzi, P., Takahashi, A., et al. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.06.001 · Cited by 13
Self-citationCinquanta, L., Infantino, M. G., & Bizzaro, N. (2021) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab132 · Cited by 15
Self-citationShovman, O., Agmon‐Levin, N., Gilburd, B., Martins, T., Petzold, A., Matthias, T., & Shoenfeld, Y. (2014) · Immunologic Research · doi:10.1007/s12026-014-8588-y · Cited by 13
Bauer, A., & Habior, A. (2019) · Annals of Laboratory Medicine · doi:10.3343/alm.2019.39.3.291 · Cited by 13
Anti-gp210 and anti-Sp100 antibodies in primary biliary cholangitis
Lamine, Z. B., Jazia, I. B., Ahmed, M. B., Slama, A. B., Baccouche, A., Slama, F., Jemaa, A., Ghédira, I., & Mankaï, A. (2021) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2021.05.006 · Cited by 12
What Is New in Primary Biliary Cirrhosis?
Bogdanos, D. P., & Gershwin, M. E. (2012) · Digestive Diseases · doi:10.1159/000341118 · Cited by 12
Self-citationNovel method for ANA quantitation using IIF imaging system
Peng, X.-D., Tang, J., Wu, Y., Yang, B., & Hu, J. (2013) · Journal of Immunological Methods · doi:10.1016/j.jim.2013.12.004 · Cited by 12
Serum autoantibodies for the diagnosis and management of autoimmune liver diseases
Achenza, M. I. S., Meda, F., Brunetta, E., & Selmi, C. F. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.12.58 · Cited by 11
Predicting and preventing autoimmunity: the case of anti-mitochondrial antibodies
Milkiewicz, M., Caballería, L., Smyk, D. S., & Milkiewicz, P. (2012) · Autoimmunity Highlights · doi:10.1007/s13317-012-0038-z · Cited by 11
Self-citationGuadalupi, G., Contini, C., Iavarone, F., Castagnola, M., Messana, I., Faa, G., Onali, S., Chessa, L., Vitorino, R. M. P., Amado, F. M. L., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512207 · Cited by 10
Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22
Smyk, D. S., Mytilinaiou, M. G., Milkiewicz, P., Rigopoulou, E. I., Invernizzi, P., & Bogdanos, D. P. (2011) · Autoimmunity Highlights · doi:10.1007/s13317-011-0023-y · Cited by 10
Self-citationRole for mycobacterial infection in pathogenesis of primary biliary cirrhosis?
Smyk, D. S. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i35.4855 · Cited by 10
Bauer, A., Habior, A., & Kraszewska, E. (2012) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2012.741088 · Cited by 10
Precision medicine in primary biliary cholangitis
Ronca, V., Gerussi, A., Cristoferi, L., Carbone, M., & Invernizzi, P. (2019) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12787 · Cited by 9
Self-citationJaskowski, T. D., Nandakumar, V., Novis, C. L., Palmer, M., & Tebo, A. E. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117219 · Cited by 8
Papamichalis, P. A., Zachou, K., Papamichali, R., Ιωάννου, Μ., Gatselis, N., Dalekos, G. N., & Koukoulis, G. Κ. (2021) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2021-0008 · Cited by 8
Self-citationKempińska‐Podhorodecka, A., Shums, Z., Wasilewicz, M. P., Wunsch, E., Milkiewicz, M., Bogdanos, D. P., Norman, G. L., & Milkiewicz, P. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/487521 · Cited by 7
Self-citationBiomarker discovery in systemic sclerosis: state of the art
Bonella, F., Patuzzo, G., & Lunardi, C. (2015) · Current Biomarker Findings · doi:10.2147/cbf.s60446 · Cited by 6
Fetomaternal alloimmunity as a cause of liver disease
Smyk, D. S., Grammatikopoulos, T., Daponte, A. I., Rigopoulou, E. I., & Bogdanos, D. P. (2011) · Autoimmunity Highlights · doi:10.1007/s13317-011-0019-7 · Cited by 6
Self-citationAlfano, A., Romito, A., Marchese, C. A., Battistini, M., Crotti, G., Ferrini, A., Mancinetti, C., Manetta, T., Mengozzi, G., Merlach, P., et al. (2016) · Immunologic Research · doi:10.1007/s12026-016-8838-2 · Cited by 6
The X-factor in primary biliary cirrhosis: monosomy X and xenobiotics
Bianchi, I., Lleò, A., Bernuzzi, F., Caliari, L., Smyk, D. S., & Invernizzi, P. (2012) · Autoimmunity Highlights · doi:10.1007/s13317-012-0043-2 · Cited by 5
Self-citationAnti-mitochondrial autoantibodies—milestone or byway to primary biliary cholangitis?
Tanaka, A. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.01.42 · Cited by 6
Metadata
- Authors
- Liu, H., Norman, G. L., Shums, Z., Worman, H. J., Krawitt, E. L., Bizzaro, N., Vergani, D., Bogdanos, D. P., Dalekos, G. N., Milkiewicz, P., Czaja, A. J., Heathcote, E. J., Hirschfield, G. M., Tan, E. M., Miyachi, K., Bignotto, M., Battezzati, P. M., Lleo, A., Leung, P. S., Podda, M., Gershwin, M. E., & Invernizzi, P.
- Affiliations
- Guangzhou Women and Children Medical Center (CN)
- Columbia University Irving Medical Center (US)
- University of Vermont (US)
- King's College London (GB)
- Pomeranian Medical University (PL)
- Mayo Clinic (US)
- University of Toronto (CA)
- Scripps Research Institute (US)
- University of Milan (IT)
- University of California, Davis (US)
- Corresponding author
- Invernizzi, Pietro
- ORCID
- Venue
- Journal of Autoimmunity
- Publisher
- Elsevier BV
- Published
- 2010-12
- Volume
- 35
- Issue
- 4
- Pages
- 436-442
- ISSN
- 0896-8411 (ISSN-L)
- OpenAlex
- W1976817326
- Cited by
- 130
- References
- 46
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 11 · 2022: 7 · 2021: 5 · 2020: 7 · 2019: 8 · 2018: 4 · 2017: 9 · 2016: 6 · 2015: 5 · 2014: 8 · 2013: 14 · 2012: 23
- FWCI
- 11.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Autoimmunity (publishedVersion)
- PubMed (publishedVersion)
- University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Keywords
- primary biliary cirrhosis, autoantibody detection, sensitivity and specificity, autoimmune hepatitis, primary sclerosing cholangitis, hepatitis B, hepatitis C, serological diagnosis
- MeSH terms
- Autoantibodies, Autoantigens, Clinical Trials as Topic, Enzyme-Linked Immunosorbent Assay, Feasibility Studies, Humans, Immunoglobulin A, Immunoglobulin G, Liver Cirrhosis, Biliary, Recombinant Fusion Proteins, Sensitivity and Specificity, Reproducibility of Results, Likelihood Functions, Immunodominant Epitopes, Mitochondrial Proteins, Nuclear Pore Complex Proteins, Antigens, Nuclear
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review